Sign Up to like & get
recommendations!
0
Published in 2019 at "Seminars in arthritis and rheumatism"
DOI: 10.1016/j.semarthrit.2018.07.005
Abstract: OBJECTIVE To study acceptance rate and factors influencing acceptance of the switch from originator etanercept (Enbrel©) to biosimilar etanercept (SB4, Bénépali©) in patients with rheumatic disease. METHODS Patients with a well-controlled rheumatic disease consulting in…
read more here.
Keywords:
acceptance rate;
switch originator;
rate;
acceptance ... See more keywords